Want $3750 in Passive Income? Invest $7500 in These 7 Stocks
These seven stocks combined can generate about $3,750 a year in passive income for an investment of just $7,500 in each one.
These seven stocks combined can generate about $3,750 a year in passive income for an investment of just $7,500 in each one.
As January wound to a close, beneficial owners, executives, and other insiders took advantage of public offerings of stock at these biotech companies.
Fourth-quarter earnings kick off in a big way in 7 to 10 days, and earnings at some of the biggest and best U.S. companies are likely expected to decline for the third…
While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors looking for growth and income. Demand is growing as the country ages;…
This year’s Artificial Intelligence rally led by the so-called “Magnificent 7” has been fantastic if you owned those stocks. The reality is the great bulk of the S&P 500 is treading water…
Here is a look at how shares of FuelCell Energy, Gilead Sciences, Starbucks and more have fared since their initial public offerings in 1992.
While many Wall Street firms are suggesting short Treasury paper and money markets now, for long-term investors looking for growth and income, healthcare is the place to be for the rest of…
Monday's top analyst upgrades and downgrades included Adobe, Apple, Arch Capital, ChargePoint, CSX, Digital Ocean, First Solar, Gilead Sciences, Lucid, Shopify and Snowflake.
Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total return potential and a degree of safety in what soon could be…
Monday's top analyst upgrades and downgrades included Amazon.com, Amgen, Apple, BioCryst Pharmaceuticals, Block, Coinbase Global, Datadog, Fortinet, Gilead Sciences, Intercontinental Exchange, Moderna, Monster Beverage, Nvidia, PayPal and Petrobras.
When Nasdaq rebalances its Nasdaq 100 index, 7 top companies in the index will be upsized, and all are Buy rated across Wall Street.
The highest-yielding stocks in the Nasdaq offer a contrarian angle for the rest of 2023. They all have some solid defensive qualities, and they are offering among the best entry points seen…
Wednesday's top analyst upgrades and downgrades included Amgen, Canadian Pacific Kansas City, Carvana, Coinbase Global, Etsy, First Horizon, GE Healthcare Technologies, Gilead Sciences, Home Depot, Mosaic, Royal Caribbean Cruises, Vornado Realty Trust,…
Monday's top analyst upgrades and downgrades included CyberArk Software, Diageo, Dish Network, Electronic Arts, Fox, Gilead Sciences, Molson Coors Beverage, O’Reilly Automotive, PacWest Bancorp, Palo Alto Networks, SoFi Technologies and Twilio.
Monday's top analyst upgrades and downgrades included Amazon.com, Bluebird Bio, Carnival, Fortinet, General Motors, Gilead Sciences, Hasbro, Hershey, Intel, International Paper, Masco, Mobileye Global, Salesforce, Snap and Waste Management.